drugset

drugset / Trial / NCT07205289

Serum Collection Study for Assay Development

NCT07205289 ↗

Phase 1 Recruiting 12 enrolled GPN Vaccines

NaSingle-groupOpen-labelDiagnostic

Summary

The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation

Timeline

Start: 2025-10
Primary completion: 2026-01
Completion: 2026-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Gamma-PN	Vaccine	500 ug	Intramuscular

Indications